Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

Vertex Pharmaceuticals Inc. sell Robert W. Baird

Vertex Pharmaceuticals Inc.
Start price
€400.05
31.01.24 / 50%
Target price
€299.00
31.01.25
Performance (%)
10.29%
End price
€441.20
01.02.25
Summary
This prediction ended on 01.02.25 with a price of €441.20. The prediction closed with a disappointing performance of 10.29%. Robert_W__Baird has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Vertex Pharmaceuticals Inc. -2.156% -2.156% -12.805%
iShares Core DAX® 2.554% 0.562% 14.142%
iShares Nasdaq 100 2.742% -0.599% 30.370%
iShares Nikkei 225® 6.584% 4.336% 49.372%
iShares S&P 500 1.930% -0.507% 24.257%

Comments by Robert_W__Baird for this prediction

In the thread Trading Vertex Pharmaceuticals Inc.
Prediction Sell
Perf. (%) 10.29%
Target price 299.000
Change
Ends at 31.01.25

Die von Robert_W__Baird gewählte maximale Laufzeit wurde überschritten

Robert W. Baird 
0
Report Share
01.02.25
In the thread Vertex Pharmaceuticals Inc. diskutieren
Prediction Sell
Perf. (%) 10.29%
Target price 299.000
Change
Ends at 31.01.25

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was downgraded by analysts at Robert W. Baird from a "neutral" rating to an "underperform" rating. They now have a $325.00 price target on the stock.
Ratings data for VRTX provided by MarketBeat

Robert W. Baird 
0
Report Share
31.01.24